First patient has been enrolled in Charité University Hospital in Berlin. Congratulations to dr. Bernhard Weschke and his team!

We are very pleased to announce that we have enrolled 10th patient in to our study. At the same time this is the first patient at Tor Vergata University, our partner from Rome. Congratulations to prof. Paolo Curatolo and his team!

On behalf of Institut National de la Sante et de la Recherche Medicale (INSERM), host of General Assembly 2014 of EPISTOP project, we are delighted to inform you that the next meeting will take place on 15th and 16th of November 2014 in Paris, France.

Representatives of each Partner of EPISTOP project will attend the meeting. During the meeting, we are going to discuss progress in project implementation and make all strategic decisions. Moreover meeting of the members of External Scientific Advisory Board will be organized at the same time. SAB members’ task is to monitor and support project activities undertaken by project Partners. Minutes from the meeting will be published on the website in November.

We are very pleased to inform that on 21st of May 2014 first EPISTOP patient has been randomized!

This part of EPISTOP project aims to compare effects of standard antiepileptic treatment in patients diagnosed as having epilepsy after clinical seizures vs after electroencephalographic epileptiform discharges. We are looking forward to enroll more patients soon in all 9 clinical sites engaged in this part of the study.

Watch the new EPISTOP promotional film